Alimera sciences reports first quarter 2023 results

Atlanta, may 15, 2023 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the first quarter of 2023.

ALIM Ratings Summary

ALIM Quant Ranking